Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
5RMGNw2dejNRVF49
